Membranous Nephropathy
Showing 1 - 25 of 1,042
T- and B-Cell Subpopulations in Membranous Nephropathy
Recruiting
- Membranous Nephropathy
- +2 more
-
Istanbul, TurkeyIstanbul University
May 31, 2023
Idiopathic Membranous Nephropathy
Not yet recruiting
- Idiopathic Membranous Nephropathy
- Obinutuzumab Injection
- (no location specified)
May 8, 2023
Primary Membranous Nephropathy Trial (MIL62, Cyclosporine)
Not yet recruiting
- Primary Membranous Nephropathy
- (no location specified)
May 16, 2023
Membranous Nephropathy Trial in Nice (Peginterferon Alfa-2A 180 MCG/ML Injectable Solution)
Not yet recruiting
- Membranous Nephropathy
- Peginterferon Alfa-2A 180 MCG/ML Injectable Solution
-
Nice, FranceCHU de NICE
Jul 4, 2023
Nephropathy, Glomerular Diseases, Idiopathic Membranous Nephropathy Trial (Huaier granule, Renin-angiotensin-aldosterone system
Not yet recruiting
- Nephropathy
- +2 more
- Huaier granule
- +2 more
- (no location specified)
Apr 20, 2023
Idiopathic Membranous Nephropathy Trial in Beijing (Rituximab, Modified Ponticelli regimen)
Recruiting
- Idiopathic Membranous Nephropathy
- Rituximab
- Modified Ponticelli regimen
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Mar 23, 2023
Membranous Nephropathy - PLA2R Induced Trial in Saint Petersburg (Rituximab, Cyclophosphamide, and Corticosteroids)
Recruiting
- Membranous Nephropathy - PLA2R Induced
- Rituximab, Cyclophosphamide, and Corticosteroids
-
Saint Petersburg, Russian FederationSt. Petersburg State Pavlov Medical University
Jan 7, 2023
Primary Membranous Nephropathy Trial (Zanubrutinib, Tacrolimus)
Not yet recruiting
- Primary Membranous Nephropathy
- (no location specified)
Jan 23, 2023
Idiopathic Membranous Nephropathy Trial in Beijing
Recruiting
- Idiopathic Membranous Nephropathy
-
Beijing, Beijing, China
- +2 more
Jan 18, 2023
PLA2R-IgG4 Detection Kit
Enrolling by invitation
- Membranous Nephropathy - PLA2R Induced
- Kidney Diseases-except Membranous Nephropathy
-
Hangzhou, ChinaZhejiangBiostar
May 6, 2023
Primary Membranous Nephropathy Trial (SNP-ACTH (1-39) Gel, Rituximab)
Not yet recruiting
- Primary Membranous Nephropathy
- SNP-ACTH (1-39) Gel
- Rituximab
- (no location specified)
Jan 13, 2023
Membranous Nephropathy Trial in China (efgartigimod IV, )
Recruiting
- Membranous Nephropathy
- efgartigimod IV
- placebo
-
Changsha, China
- +8 more
Apr 11, 2023
Primary Membranous Nephropathy Trial in Australia (Obinutuzumab, Oral prednisolone and cyclophosphamide)
Not yet recruiting
- Primary Membranous Nephropathy
- Obinutuzumab
- Oral prednisolone and cyclophosphamide
-
Garran, Australian Capital Territory, Australia
- +12 more
Nov 1, 2023
Autoreactive B Cells in Membranous Nephropathy
Recruiting
- Membranous Nephropathy
- In vitro assays.
-
Ranica, BG, ItalyCentro di Ricerche Cliniche per le Malattie Rare " Aldo e Cele D
Nov 2, 2022
Prognostic Model of TAC in the Treatment of MN
Not yet recruiting
- Idiopathic Membranous Nephropathy
- (no location specified)
Dec 28, 2022
Prognostic Model of GC/CTX in the Treatment of MN
Not yet recruiting
- Idiopathic Membranous Nephropathy
- glucocorticoid + cytoxan
- (no location specified)
Dec 28, 2022
Idiopathic Membranous Nephropathy Trial (glucocorticoid + tacrolimus)
Not yet recruiting
- Idiopathic Membranous Nephropathy
- glucocorticoid + tacrolimus
- (no location specified)
Dec 28, 2022
Primary Membranous Nephropathy Trial in Beijing (B007)
Not yet recruiting
- Primary Membranous Nephropathy
-
Beijing, ChinaPeking university first hospital
Dec 20, 2022
Nephrotic Syndrome, Proteinuria, Autoimmune Disease Trial run by the NIDDK (Rituximab Infusion, Oral Cyclosporine)
Recruiting
- Nephrotic Syndrome
- +4 more
- Rituximab Infusion
- Oral Cyclosporine
-
Bethesda, Maryland
- +1 more
Jan 25, 2023
Idiopathic Membranous Nephropathy Trial (Rituximab, Cyclophosphamide)
Not yet recruiting
- Idiopathic Membranous Nephropathy
- (no location specified)
Aug 22, 2022
Membranous Nephropathy Trial in New York (ACTHar)
Completed
- Membranous Nephropathy
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jul 20, 2022
Urinary Biomarker in Membranous Glomerulonephritis
Not yet recruiting
- Membranous Nephropathy
- urinary markers
- (no location specified)
Jan 18, 2023
Glomerulonephritis, Membranous, Nephrotic Syndrome,Idiopathic Trial in Japan (Rituximab (genetical recombination), Placebo)
Not yet recruiting
- Glomerulonephritis, Membranous
- Nephrotic Syndrome,Idiopathic
- Rituximab (genetical recombination)
- Placebo
-
Anjo, Aichi, Japan
- +7 more
Jun 13, 2023